Browsing by Subject "Rheumatic Diseases"
Now showing items 1-2 of 2
-
Hydroxychloroquine: a potential ethical dilemma for rheumatologists during the COVID-19 pandemic
(2020-04)Two antimalarial agents, chloroquine (CQ) and hydroxychloroquine (HCQ), have been trusted treatments for a range of rheumatic diseases over the past seventy years [1]. These agents have attracted intense media attention ... -
Similar incidence of Coronavirus Disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy
(2020-05-20)Background: Hydroxychloroquine is currently being tested as post-exposure prophylaxis against coronavirus disease 2019 (COVID-19) in several ongoing clinical trials. Objective: To compare the incidence of COVID-19 in Spanish ...